An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma

Overview of attention for article published in Blood Advances, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,437 followers.

RT @PaperbirdsM: New article: An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lympho…

New article: An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma https://t.co/7KDe06bPfb #FL #lymsm #hematology https://t.co/aAc0O0oUUu

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.